je.st
news
Home
› Virttu Biologics: US Phase I study is extended to include systemic delivery of oncolytic virus
Virttu Biologics: US Phase I study is extended to include systemic delivery of oncolytic virus
2013-05-31 14:59:36| Logistics - Topix.net
"This welcome decision by regulatory bodies, both further validates the safety profile of SEPREHVIR and demonstrates its potential broad utility.
Tags: include
study
delivery
extended
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|